EUVIMEDEUVIMED entdecken
Crossref

Immune‐deficient MISTRG mice support expansion of leukaemia‐initiating cells in xenograft models of paediatric acute myeloid leukaemia

Patrick Connerty iD, Jinhan Xie, Fatima El-Najjar, Toby N Trahair, Nisitha Jayatilleke, Chelsea Mayoh, Richard B Lock iD

British Journal of Haematology · 2025

DOI: 10.1111/bjh.20029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Patrick Connerty und 6 weiteren Autor:innen. Beteiligte Einrichtung: Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health, UNSW Centre for Childhood Cancer Resea…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Neoplastic Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Health and Medical Research Council, Tour de Cure, Anthony Rothe Memorial Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukaemia (AML) remains a deadly disease, largely due to the persistence of drug‐resistant leukaemia‐initiating cells (LICs) which promote relapse. Therefore, effective therapies must target LICs. Patient‐derived xenografts (PDXs) are valuable for testing new therapies, though establishing AML PDX models is challenging. Two humanized mouse strains, MISTRG and NRGS, have been developed for this purpose. In this study, we show both are suitable strains for the development of AML PDXs; however, MISTRG‐derived PDXs contain 10 times higher LIC frequencies than NRGS‐derived PDXs. These differences have crucial implications for preclinical AML therapy testing and modelling relapse models of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteNeoplastic Stem CellsAnimalsMiceHumansDisease Models, AnimalChildHeterograftsXenograft Model Antitumor Assays

Stichwörter der Autor:innen

MISTRGNRGSacute myeloid Leukaemialeukaemia‐initiating cellspatient‐derived xenograft

Autor:innen und Institutionen

  • Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health, UNSW Centre for Childhood Cancer Research, UNSW Sydney, Sydney, New South Wales, Australia.
  • Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.

ORCID-Profile: Patrick Connerty, Richard B Lock

Förderung

  • National Health and Medical Research Council
  • Tour de Cure
  • Anthony Rothe Memorial Trust

Zitieren

APA

Connerty, P., Xie, J., El-Najjar, F., Trahair, T. N., Jayatilleke, N., Mayoh, C., & Lock, R. B. (2025). Immune‐deficient MISTRG mice support expansion of leukaemia‐initiating cells in xenograft models of paediatric acute myeloid leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.20029

Vancouver

Connerty P, Xie J, El-Najjar F, Trahair TN, Jayatilleke N, Mayoh C, et al. Immune‐deficient MISTRG mice support expansion of leukaemia‐initiating cells in xenograft models of paediatric acute myeloid leukaemia. British Journal of Haematology. 2025. doi:10.1111/bjh.20029

BibTeX
@article{Connerty2025,
  author = {Connerty, Patrick and Xie, Jinhan and El-Najjar, Fatima and Trahair, Toby N and Jayatilleke, Nisitha and Mayoh, Chelsea and Lock, Richard B},
  title = {Immune‐deficient MISTRG mice support expansion of leukaemia‐initiating cells in xenograft models of paediatric acute myeloid leukaemia},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.20029}
}
Kostenlos starten →